Belite Bio, Inc
Belite Bio, Inc (BLTE) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
blte · stock forecast · 6 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 6 Wall Street analysts in the past 3 months
Buy
6 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$217
Consensus
$208
+49.2% upside
Low
$191
Median: $215 · Last Close: $139.46
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$208.00
49.2% upside
High Target
$217
55.6%
Low Target
$191
37.0%
Current Price
$139.46
as of today
Based on analyst price targets, the BLTE stock price prediction for the next 12 months ranges from $191 to $217. The consensus BLTE price forecast of $208.00 implies 49.2% upside from the current price of $139.46.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $136.58 | ↓ 2.06% |
1-day model range: $135.84–$137.31. Peak: $137.31 (-2.06%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $251 | +80.0% |
| 2028 | $372 | +166.4% |
| 2029 | $479 | +243.1% |
| 2030 | $561 | +302.4% |
| 2031 | — | +344.1% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BLTE · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-26 | Mizuho | Maintains | Outperform→Outperform |
| 2026-05-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-03 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-03-03 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2026-01-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-02 | Mizuho | Upgrade ↑ | Neutral→Outperform |
| 2025-12-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Belite Bio, Inc (BLTE) stock. Of the recent 44 rating actions, 1 were upgrades and 0 were downgrades. 6 analysts currently cover BLTE.
Analyst Recommendation Trends
BLTE analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 2 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$23M
↓ 95.8% YoY
Revenue Next Year
$243M
↑ 979.2% YoY
EPS This Year
$-3.19
EPS Next Year
$0.84
↓ 126.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast BLTE EPS of $-3.19 for the current fiscal year, based on estimates from 6 analysts. The BLTE revenue forecast is $23M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BLTE stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BLTE price target is $208.00 (+49.2% upside), with an analyst consensus of Buy.
The BLTE short-term stock prediction for tomorrow is $136.58 (-2.06%). The BLTE stock price prediction for 2027 estimates an average of $251. The BLTE stock prediction for 2030 projects a range of $528–$594.
Belite Bio, Inc trades on NASDAQ under the ticker BLTE. The BLTE stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
BLTE forecast · 8 questionsAccording to 6 Wall Street analysts, the average 12-month BLTE price target is $208.00, with a high forecast of $217.00 and a low of $191.00. The median price target is shown in the chart above when available. This implies +49.2% potential upside from the current price of $139.46.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.